Painreform Stock Forward View
| PRFX Stock | USD 2.48 -0.10 -3.88% |
Price forecasting for Painreform requires integrating several analytical layers. This module contributes the sentiment layer - assessing whether investor enthusiasm around Painreform is driving its price away from fundamental value.
As of now, the 14-period RSI for Painreform is 0, signaling extreme oversold conditions. Historically, RSI levels this depressed have preceded relief bounces, though the magnitude and duration vary widely.Momentum
Sell Peaked
Oversold | Overbought |
Wall Street Target Price 12 |
The hype summary for Painreform aligns attention signals with price movement and peers.
The Naive Prediction forecasted value of Painreform on the next trading day is expected to be 2.00 with a mean absolute deviation of 0.28 and the sum of the absolute errors of 16.86.Painreform after-hype prediction price | $ 2.4 |
The sentiment summary complements forecasting and technical views with analyst estimates and earnings data.
Painreform | Build portfolio with Painreform Stock |
Painreform Additional Predictive Modules
Forecasting Painreform's price movement relies on structured analysis of indicator behavior, momentum signatures, and historical volatility patterns. No prediction model eliminates uncertainty; the goal is to identify scenarios with favorable risk-adjusted probabilities.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Painreform Cash Forecast
Forecasting financial indicators like cash flow involves applying various statistical methods, techniques, and algorithms that reveal hidden trends within Painreform's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2018-03-31 | Previous Quarter 3.5 M | Current Value 3.5 M | Quarterly Volatility 6.7 M |
Macro event markers
Naive Prediction Price Forecast For the 18th of March 2026
Given 90 days horizon, the Naive Prediction forecasted value of Painreform on the next trading day is expected to be 2.00 with a mean absolute deviation of 0.28 , mean absolute percentage error of 0.13 , and the sum of the absolute errors of 16.86 .Please note that although there have been many attempts to predict Painreform Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Painreform's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Painreform | Painreform Price Prediction | Research Analysis |
Forecasted Value
Forecasting Painreform for the next session involves measuring the model's historical ability to define credible downside and upside scenarios. Used properly, these levels provide context around forecast dispersion rather than certainty about the next closing print.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Painreform stock data series using in forecasting. Note that when a statistical model is used to represent Painreform stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.0487 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2764 |
| MAPE | Mean absolute percentage error | 0.0767 |
| SAE | Sum of the absolute errors | 16.862 |
Mean reversion in Painreform's price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
After-Hype Price Density Analysis
Understanding Painreform's probability distribution helps investors calibrate position size to their risk tolerance. The tails of the Painreform distribution capture low-probability but high-impact outcomes that naive point estimates ignore.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Using Painreform's historical news impact data, we estimate the likely price corridor for the next trading session after a significant headline. Painreform's after-hype downside and upside margins for the prediction period are 0.12 and 10.08, respectively. Note that past news reactions for Painreform are not guaranteed to repeat, particularly in novel market environments.
Current Value
This after-hype projection for Painreform uses a 3 months horizon to examine how price may behave after short-term sentiment effects dissipate. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Painreform is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Painreform backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Painreform, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.79 | 7.68 | 0.08 | 0.08 | 9 Events | 7 Events | In 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.48 | 2.40 | 3.23 |
|
Hype Timeline
Painreform is at this time traded for 2.48. The company has historical hype elasticity of -0.08, and average elasticity to hype of competition of -0.08. Painreform is forecasted to decline in value after the next headline, with the price expected to drop to 2.4. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -3.23%, whereas the daily expected return is at this time at -0.79%. The volatility of related hype on Painreform is about 7718.59%, with the expected price after the next announcement by competition of 2.40. The company has price-to-book ratio of 0.26. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Painreform recorded earnings per share (EPS) of 29.9. The company had not issued any dividends in recent years. The firm completed a 1:6 stock split on 9th of September 2024. Given the investment horizon of 90 days the next forecasted press release will be in 9 days. Historical Fundamental Analysis of Painreform can be used to cross-verify projections for Painreform. The view supplies historical context for the projection discussion.Related Hype Analysis
Understanding how Painreform's direct competitors react to news events helps investors anticipate contagion effects and sector-wide sentiment shifts that may affect Painreform's performance.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| UPC | Universe Pharmaceuticals | 0.11 | 7 per month | 0.00 | -0.07 | 9.55 | -10.18 | 52.35 | |
| WINT | Windtree Therapeutics | 0.00 | 4 per month | 0.00 | -0.09 | 0.00 | -25.00 | 150.00 | |
| ELAB | Elevai Labs Common | 0.18 | 7 per month | 0.00 | -0.39 | 8.62 | -23.72 | 53.38 | |
| NKGN | NKGen Biotech Common | 0.42 | 26 per month | 12.78 | 0.13 | 35.14 | -14.29 | 298.33 | |
| DRMA | Dermata Therapeutics | -0.03 | 7 per month | 0.00 | -0.06 | 16.48 | -16.23 | 80.83 | |
| PBM | Psyence Biomedical Ltd | -0.06 | 9 per month | 0.00 | -0.20 | 9.96 | -12.68 | 48.52 | |
| ATXI | Avenue Therapeutics | -1.74 | 15 per month | 0.00 | -0.02 | 22.22 | -21.43 | 122.38 | |
| VRAX | Virax Biolabs Group | -0.03 | 4 per month | 0.00 | -0.21 | 8.57 | -9.76 | 23.38 | |
| NCEL | NewcelX | 0.14 | 4 per month | 0.00 | -0.04 | 11.55 | -12.61 | 39.40 | |
| XRTX | XORTX Therapeutics | 0.01 | 5 per month | 0.00 | -0.12 | 7.02 | -8.33 | 25.64 |
Other Forecasting Options for Painreform
The price movement of Painreform is a central concern for all potential investors, regardless of their level of expertise. Painreform Stock price charts can be difficult to interpret due to the noise present in the data.Painreform Related Equities
The following equities are related to Painreform within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Painreform against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Painreform Market Strength Events
Market strength indicators applied to Painreform stock help investors assess the relative momentum and resilience of the security in different market environments. By using these indicators, traders can make more informed decisions about when to buy or sell Painreform.
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 2.48 | |||
| Day Typical Price | 2.48 | |||
| Price Action Indicator | -0.05 | |||
| Period Momentum Indicator | -0.10 |
Painreform Risk Indicators
Risk indicator analysis for Painreform is essential for accurately projecting its future price trajectory. By identifying the level of risk embedded in Painreform's investment, investors can make informed decisions about position sizing and risk mitigation.
| Mean Deviation | 5.0 | |||
| Standard Deviation | 7.66 | |||
| Variance | 58.65 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Painreform
The amount of media and story coverage tied to Painreform can signal where market attention is concentrating at the moment. A disciplined read of coverage helps investors separate durable relevance from temporary noise.
Contributor Headline
Latest Perspective From Macroaxis
Painreform Short Properties
Reviewing short-oriented indicators for Painreform is useful because long and short participants often create very different signals for timing and volatility. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 18.1 K | |
| Cash And Short Term Investments | 4.3 M |
More Resources for Painreform Stock Analysis
Understanding Painreform typically begins with financial statements and long-term trend review. Ratios and trend metrics help frame Painreform's operating context across reporting periods. Key reports that frame Painreform Stock are listed below:Historical Fundamental Analysis of Painreform can be used to cross-verify projections for Painreform. The view supplies historical context for the projection discussion. To learn how to invest in Painreform Stock, please use our How to Invest in Painreform guide.Painreform currently shows ROE of -127.65%, market cap of 1.87 Million. Investors get more value from Painreform analysis when it is combined with the construction and diversification tools listed below. Painreform analysis across multiple dimensions - risk, valuation, diversification - produces a more informed position-sizing decision. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Investors evaluate Painreform using market value and book value, each describing different facets of the business. Painreform's market capitalization is 1.87 M. A P/B ratio of 0.26 suggests Painreform trades near or below book value. Intrinsic value reflects what Painreform's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
Value and price for Painreform are related but not identical, and they can diverge across cycles. For Painreform, key inputs include a P/B ratio of 0.26, and ROE of -127.65%. The quoted Painreform price is the exchange level where supply meets demand.